We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-14.99%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$290M
AUM Growth
-$60.2M
Cap. Flow
-$11.2M
Cap. Flow %
-3.87%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$10.7M
2
ALKS icon
Alkermes
ALKS
+$500K

Sector Composition

Rank Sector Weight
1 Healthcare 96.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$200M 68.93%
14,413,873
-587,200
-4% -$10.7M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$68.1M 23.47%
2,679,835
ALKS icon
3
Alkermes
ALKS
$8.82B
$10.1M 3.46%
864,417
-27,983
-3% -$500K
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$6.22M 2.14%
320,000
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$5.23M 1.8%
400,000
CLDX icon
6
Celldex Therapeutics
CLDX
$2.77B
$563K 0.19%
420,846

Similar funds

Meditor Group's Q1 2020 Portfolio in Review

As of Q1 2020, Meditor Group held 6 positions worth $290M, down 17% from $351M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $11.2M in Q1 2020, reducing 2 holdings. Its largest reduction was Exelixis, cutting an estimated $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

  • Meditor Group's biggest Q1 2020 reduction was Exelixis, cutting an estimated $10.7M.
  • Meditor Group's ten largest holdings make up 100% of its $290M portfolio in Q1 2020.
  • Meditor Group opened 0 new positions and closed 0 in Q1 2020.
  • Meditor Group's portfolio value fell 17% quarter-over-quarter to $290M.

Based on Meditor Group's 13F filing for Q1 2020, filed 30 Apr 2020.